ClostraBio Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Impact of CLB101TM️ on Gut Health in Healthy, Overweight Individuals (NCT07336615) | ClostraBio Inc. | 2025-10-09 |
Track ClostraBio Inc. automatically
Every clearance here is in the API, with alerts when new ones post.